Akums Drugs ties up with Microcore Research to manufacture NESM supplements for healthy joints
With this tie-up, Akums will leverage NESM and develop dietary supplements for maintaining healthy joint and connective tissues
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
Lupin signs agreement to acquire two inhalation brands from Sunovion
The company expects the transaction to be accretive to earnings in the first year
Marksans acquires capacity from Tevapharm India
The transaction is in cash consideration, and is expected to be finalised by 1st April, 2023, subject to the usual closing…
Grifols in 15-year deal with Canada for plasma-based medicines
Under the agreement, Grifols, which uses blood plasma to make medicines, will work with Canadian Blood Services (CBS) to also…
Lupin and DKSH sign exclusive licensing and supply agreement to market five biosimilar candidates in…
According to the agreement, Lupin’s subsidiary in Philippines, Multicare Pharma, will file for marketing approval and be…
Pharma deals value decreases by 14.8 per cent in August 2022: GlobalData
The industry reported 120 Venture Capital (VC) deals worth $2.6 billion in August 2022, compared to the last 12-month average…
Sonde Health inks multi-year partnership with Koye Pharma
Strategic partnership created to develop and license a new vocal biomarker detection and monitoring capability for COPD in India
Swiss eye-care firm Alcon to buy Aerie Pharma for about $753 million
The deal will add Aerie's Rocklatan and Rhopressa eye drops, along with a pipeline of many clinical and pre-clinical ophthalmic…
Roche Pharma India and SKCC, USA launch ACMO in India for oncologists/pathologists
One-of-its-kind programme to train more than 100 cancer specialists, pathologists in personalised medicine
Indoco launches initiative to promote green energy
This is in compliance with the regulatory requirement for being a ‘captive user’, under the Indian Electricity laws
Gerresheimer and Zollner enter into strategic partnership for electronically controlled medtech…
The two companies tap into growing demand for digital and connected drug delivery and diagnostic systems
CCI clears deal involving Sekhmet Pharmaventures and Optimus Drugs
Under the transaction, Sekhmet would buy a majority shareholding in Optimus Drugs
AstraZeneca completes acquisition of TeneoTwo
AstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100 million
BSV partners with IISc for research on next-gen snakebite therapy
Supports research of antibodies and anti-venom development at the IISc Evolutionary Venomics Laboratory facility
Azenta to acquire B Medical Systems
The transaction is expected to close in October 2022
Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare haematology
Proposed acquisition drives growth by bringing leading sickle cell disease expertise, portfolio and pipeline to Pfizer with…
China’s Innovent Biologics secures over $300 million investment from Sanofi
The all-cash investment by Sanofi unit Sanofi Foreign Participations BV will be at a price of $42.42 per Innovent share,…
Amgen bets on ChemoCentryx’s rare disease drug in $3.7 billion deal
Amgen has been facing stiff competition for its top-selling arthritis drug, Enbrel, from newer branded treatments and patents for…
Dr Reddy’s Laboratories enters into licensing agreement with Slayback Pharma
The partnership aims to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify in the US
Sun Pharma and Cosmo announce territory expansion of license and supply agreements for WINLEVI
The new agreement includes Japan, Australia, New Zealand, Brazil, Mexico and Russia